title: Reanalyzing reverse payment settlements: a solution to the patentee's dilemma.
authors.forename: Zhenghui
authors.initials: Z
authors.lastname: Wang
mesh_terms: D016363:Antitrust Laws; D017277:Drug Approval / Q000191:economics* / Q000331:legislation & jurisprudence*; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000191:economics; D004465:Economic Competition / Q000331:legislation & jurisprudence; D006801:Humans; D007880:Legislation, Drug / Q000191:economics*; D008389:Marketing of Health Services / Q000191:economics* / Q000331:legislation & jurisprudence*; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D035521:Supreme Court Decisions; D014481:United States; D014485:United States Federal Trade Commission / Q000191:economics / Q000331:legislation & jurisprudence
chemical_list: D016568:Drugs, Generic